Artal Group S.A. Agenus Inc Call Options Transaction History
Artal Group S.A.
- $1.86 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AGEN
# of Institutions
128Shares Held
205MCall Options Held
1.18MPut Options Held
69.8K-
Vanguard Group Inc Valley Forge, PA34.4MShares$574 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT31.7MShares$529 Million0.61% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct30.1MShares$503 Million0.04% of portfolio
-
Black Rock Inc. New York, NY29.2MShares$488 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA8.1MShares$135 Million0.0% of portfolio
About AGENUS INC
- Ticker AGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 283,163,008
- Market Cap $4.73B
- Description
- Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...